The Role of Bone Health Agents in Patients with Prostate Cancer - Tia Higano

October 31, 2018

(Length of interview: 11 minutes)

Tia Higano and Alicia Morgans share their perspective on the data analysis from the ERA-223 phase III study and highlight the value of incorporating bone health management, weight-bearing and resistance exercise when treating patients with prostate cancer.


Celestia (Tia) S. Higano, MD, Director, Prostate Cancer Clinical Research Group, Seattle Cancer Care Alliance and a prostate cancer specialist and Professor of Medicine at the University of Washington School of Medicine and a member of Fred Hutchinson Cancer Research Center.   

Alicia Morgans, MD, MPH